uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Qizenday
Application withdrawn
Human
Details
EMA number
EMEA/H/C/004153
ATC code
A11HA05
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of progressive multiple sclerosis (primary or secondary)
MeSH:
Multiple Sclerosis
Group:
Vitamins
Marketing Authorisation Holder
Medday Pharmaceuticals
MAH
Qizenday | uMedical